Literature DB >> 2477706

Autoimmune disease: immunotherapy by peptides?

C A Janeway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2477706     DOI： 10.1038/341482a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

Review 1.  A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease.

Authors:  D C Wraith; D E Smilek
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Approaches toward peptide-based immunotherapy of autoimmune diseases.

Authors:  L Adorini; J C Guéry; S Trembleau
Journal:  Springer Semin Immunopathol       Date:  1992

3.  A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens.

Authors:  L B Nicholson; A Murtaza; B P Hafler; A Sette; V K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  Clinical immunology.

Authors:  R J Powell
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

Review 5.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

6.  A VISTA on PD-1H.

Authors:  Yang Liu
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

7.  Mercury-induced autoreactive anti-class II T cell line protects from experimental autoimmune encephalomyelitis by the bias of CD8+ antiergotypic cells in Lewis rats.

Authors:  M Castedo; L Pelletier; J Rossert; R Pasquier; H Villarroya; P Druet
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

8.  Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat-shock protein.

Authors:  X D Yang; J Gasser; U Feige
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

9.  Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.

Authors:  J C Guéry; A Sette; J Leighton; A Dragomir; L Adorini
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

10.  A subpopulation of mouse cytotoxic T lymphocytes recognizes allogeneic H-2 class I antigens in the context of other H-2 class I molecules.

Authors:  F Kievits; P Ivanyi
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.